TNF‐α blockers intervention vs placebo or additional treatment
Incidence of coronary artery abnormalities · children diagnosed with Kawasaki disease
TNF‐α blockers intervention showed no clear difference in incidence of coronary artery abnormalities compared with placebo or additional treatment (low certainty).
1 finding from 1 review
- TNF‐α blockers for the treatment of Kawasaki disease in children 2019 · Cochrane Headline outcomes onlyRR 1.18 [0.45, 3.12]3 studies · 270 participantsLow